Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 399

1.

A perspective on causation of the chronic fatigue syndrome by considering its nosology.

White PD.

J Eval Clin Pract. 2019 Aug 1. doi: 10.1111/jep.13240. [Epub ahead of print]

PMID:
31373106
2.

Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes.

Carr MJ, Ashcroft DM, White PD, Kapur N, Webb RT.

Psychol Med. 2019 May 27:1-8. doi: 10.1017/S0033291719001065. [Epub ahead of print]

PMID:
31131782
3.

Protocol for a multicentre randomised controlled parallel-group trial to compare the effectiveness of remotely delivered cognitive-behavioural and graded exercise interventions with usual care alone to lessen the impact of fatigue in inflammatory rheumatic diseases (LIFT).

Martin KR, Bachmair EM, Aucott L, Dures E, Emsley R, Gray SR, Hewlett S, Kumar V, Lovell K, Macfarlane GJ, MacLennan G, McNamee P, Norrie J, Paul L, Ralston S, Siebert S, Wearden A, White PD, Basu N.

BMJ Open. 2019 Jan 30;9(1):e026793. doi: 10.1136/bmjopen-2018-026793.

4.

The International Collaborative on Fatigue Following Infection (COFFI).

Katz BZ, Collin SM, Murphy G, Moss-Morris R, Wyller VB, Wensaas KA, Hautvast JLA, Bleeker-Rovers CP, Vollmer-Conna U, Buchwald D, Taylor R, Little P, Crawley E, White PD, Lloyd A.

Fatigue. 2018;6(2):106-121. doi: 10.1080/21641846.2018.1426086. Epub 2018 Jan 19.

5.

Graded exercise self-help for chronic fatigue syndrome in GETSET - Authors' reply.

Clark LV, Pesola F, Thomas JM, Vergara-Williamson M, Beynon M, White PD.

Lancet. 2018 Mar 24;391(10126):1162. doi: 10.1016/S0140-6736(18)30684-6. No abstract available.

PMID:
29595495
6.

Tutorial: The practical application of longitudinal structural equation mediation models in clinical trials.

Goldsmith KA, MacKinnon DP, Chalder T, White PD, Sharpe M, Pickles A.

Psychol Methods. 2018 Jun;23(2):191-207. doi: 10.1037/met0000154. Epub 2017 Dec 28.

7.

Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors.

Duncan M, Moschopoulou E, Herrington E, Deane J, Roylance R, Jones L, Bourke L, Morgan A, Chalder T, Thaha MA, Taylor SC, Korszun A, White PD, Bhui K; SURECAN Investigators.

BMJ Open. 2017 Nov 28;7(11):e015860. doi: 10.1136/bmjopen-2017-015860. Review.

8.

Response to the editorial by Dr Geraghty.

White PD, Chalder T, Sharpe M, Angus BJ, Baber HL, Bavinton J, Burgess M, Clark LV, Cox DL, DeCesare JC, Goldsmith KA, Johnson AL, McCrone P, Murphy G, Murphy M, O'Dowd H, Potts L, Walwyn R, Wilks D.

J Health Psychol. 2017 Aug;22(9):1113-1117. doi: 10.1177/1359105316688953. Epub 2017 Jan 24.

PMID:
28805524
9.

Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Clark LV, Buckland M, Murphy G, Taylor N, Vleck V, Mein C, Wozniak E, Smuk M, White PD.

Clin Exp Immunol. 2017 Dec;190(3):360-371. doi: 10.1111/cei.13023. Epub 2017 Oct 11.

10.

Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial.

Clark LV, Pesola F, Thomas JM, Vergara-Williamson M, Beynon M, White PD.

Lancet. 2017 Jul 22;390(10092):363-373. doi: 10.1016/S0140-6736(16)32589-2. Epub 2017 Jun 22.

11.

Health care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study.

Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD.

BMC Fam Pract. 2017 May 5;18(1):60. doi: 10.1186/s12875-017-0635-z.

12.

Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001-2013: a Clinical Practice Research Datalink study.

Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD.

J R Soc Med. 2017 Jun;110(6):231-244. doi: 10.1177/0141076817702530. Epub 2017 Mar 30.

13.

A survey to determine usual care after cancer treatment within the United Kingdom national health service.

Duncan M, Deane J, White PD, Ridge D, Roylance R, Korszun A, Chalder T, Bhui KS, Thaha MA, Bourke L; SURECAN investigators.

BMC Cancer. 2017 Mar 11;17(1):186. doi: 10.1186/s12885-017-3172-1.

14.

Heterogeneity in chronic fatigue syndrome - empirically defined subgroups from the PACE trial.

Williams TE, Chalder T, Sharpe M, White PD.

Psychol Med. 2017 Jun;47(8):1454-1465. doi: 10.1017/S0033291716003615. Epub 2017 Jan 23.

PMID:
28112075
15.

HF-Free Boc Synthesis of Peptide Thioesters for Ligation and Cyclization.

Raz R, Burlina F, Ismail M, Downward J, Li J, Smerdon SJ, Quibell M, White PD, Offer J.

Angew Chem Int Ed Engl. 2016 Oct 10;55(42):13174-13179. doi: 10.1002/anie.201607657.

16.

Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials.

Goldsmith KA, Chalder T, White PD, Sharpe M, Pickles A.

Stat Methods Med Res. 2018 Jun;27(6):1615-1633. doi: 10.1177/0962280216666111. Epub 2016 Sep 19.

17.

A UK based review of recommendations regarding the management of chronic fatigue syndrome.

Mallet M, King E, White PD.

J Psychosom Res. 2016 Sep;88:33-5. doi: 10.1016/j.jpsychores.2016.07.008. Epub 2016 Jul 17.

PMID:
27521650
18.

Complementary and alternative healthcare use by participants in the PACE trial of treatments for chronic fatigue syndrome.

Lewith G, Stuart B, Chalder T, McDermott C, White PD.

J Psychosom Res. 2016 Aug;87:37-42. doi: 10.1016/j.jpsychores.2016.06.005. Epub 2016 Jun 10.

PMID:
27411750
19.

Graded Exercise Therapy Guided Self-Help Trial for Patients with Chronic Fatigue Syndrome (GETSET): Protocol for a Randomized Controlled Trial and Interview Study.

Clark LV, McCrone P, Ridge D, Cheshire A, Vergara-Williamson M, Pesola F, White PD.

JMIR Res Protoc. 2016 Jun 8;5(2):e70. doi: 10.2196/resprot.5395.

20.

Chronic fatigue syndrome (CFS) symptom-based phenotypes in two clinical cohorts of adult patients in the UK and The Netherlands.

Collin SM, Nikolaus S, Heron J, Knoop H, White PD, Crawley E.

J Psychosom Res. 2016 Feb;81:14-23. doi: 10.1016/j.jpsychores.2015.12.006. Epub 2015 Dec 23.

PMID:
26800634
21.

Patient reaction to the PACE trial - Authors' reply.

Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD.

Lancet Psychiatry. 2016 Feb;3(2):e8-9. doi: 10.1016/S2215-0366(16)00018-3. Epub 2016 Jan 19. No abstract available.

PMID:
26795760
22.

Comment on: 'Reports of recovery in chronic fatigue syndrome may present less than meets the eye'.

White PD, Chalder T, Sharpe M.

Evid Based Ment Health. 2016 Feb;19(1):32. doi: 10.1136/eb-2015-102300. No abstract available.

PMID:
26792831
23.

Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

White PD, Clauw DJ, van der Meer JW, Moss-Morris R, Taylor RR.

Ann Intern Med. 2015 Dec 1;163(11):885. doi: 10.7326/L15-5171. No abstract available.

PMID:
26618291
24.

Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.

Sharpe M, Goldsmith KA, Johnson AL, Chalder T, Walker J, White PD.

Lancet Psychiatry. 2015 Dec;2(12):1067-74. doi: 10.1016/S2215-0366(15)00317-X. Epub 2015 Oct 28.

PMID:
26521770
25.

Methods and outcome reporting in the PACE trial--Author's reply.

Chalder T, Goldsmith KA, White PD, Sharpe M, Pickles AR.

Lancet Psychiatry. 2015 Apr;2(4):e10-1. doi: 10.1016/S2215-0366(15)00114-5. Epub 2015 Mar 31. No abstract available.

PMID:
26360091
26.

Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial.

Chalder T, Goldsmith KA, White PD, Sharpe M, Pickles AR.

Lancet Psychiatry. 2015 Feb;2(2):141-52. doi: 10.1016/S2215-0366(14)00069-8. Epub 2015 Jan 28.

PMID:
26359750
27.

The planning, implementation and publication of a complex intervention trial for chronic fatigue syndrome: the PACE trial.

White PD, Chalder T, Sharpe M.

BJPsych Bull. 2015 Feb;39(1):24-7. doi: 10.1192/pb.bp.113.045005.

28.

Chronic fatigue syndrome and circulating cytokines: A systematic review.

Blundell S, Ray KK, Buckland M, White PD.

Brain Behav Immun. 2015 Nov;50:186-195. doi: 10.1016/j.bbi.2015.07.004. Epub 2015 Jul 3. Review.

PMID:
26148446
29.

The common link between functional somatic syndromes may be central sensitisation.

Bourke JH, Langford RM, White PD.

J Psychosom Res. 2015 Mar;78(3):228-36. doi: 10.1016/j.jpsychores.2015.01.003. Epub 2015 Jan 9. Review.

PMID:
25598410
30.

A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.

Walwyn R, Potts L, McCrone P, Johnson AL, DeCesare JC, Baber H, Goldsmith K, Sharpe M, Chalder T, White PD.

Trials. 2013 Nov 13;14:386. doi: 10.1186/1745-6215-14-386.

31.

PACE trial authors' reply to letter by Kindlon.

White PD, Chalder T, Sharpe M, Johnson T, Goldsmith K.

BMJ. 2013 Oct 15;347:f5963. doi: 10.1136/bmj.f5963. No abstract available.

PMID:
24129374
32.

The prospective association between childhood cognitive ability and somatic symptoms and syndromes in adulthood: the 1958 British birth cohort.

Kingma EM, Rosmalen JG, White PD, Stansfeld SA, Clark C.

J Epidemiol Community Health. 2013 Dec 1;67(12):1047-53. doi: 10.1136/jech-2013-202850. Epub 2013 Sep 10.

33.

Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial.

Bourke JH, Johnson AL, Sharpe M, Chalder T, White PD.

Psychol Med. 2014 May;44(7):1545-52. doi: 10.1017/S0033291713002201. Epub 2013 Aug 23.

PMID:
23967878
34.

Letter to the editor: response to correspondence concerning 'recovery from chronic fatigue syndrome after treatments in the PACE trial'.

White PD, Goldsmith K, Johnson AL, Chalder T, Sharpe M.

Psychol Med. 2013 Aug;43(8):1791-2. doi: 10.1017/S0033291713001311. No abstract available.

PMID:
23866117
35.

How to assess common somatic symptoms in large-scale studies: a systematic review of questionnaires.

Zijlema WL, Stolk RP, Löwe B, Rief W; BioSHaRE, White PD, Rosmalen JG.

J Psychosom Res. 2013 Jun;74(6):459-68. doi: 10.1016/j.jpsychores.2013.03.093. Epub 2013 Apr 24. Review.

PMID:
23731742
36.

Is sharing data from clinical trials always a good idea?

White PD.

BMJ. 2013 May 28;346:f3379. doi: 10.1136/bmj.f3379. No abstract available.

PMID:
23714258
37.

Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database.

Crawley E, Collin SM, White PD, Rimes K, Sterne JA, May MT; CFS/ME National Outcomes Database.

QJM. 2013 Jun;106(6):555-65. doi: 10.1093/qjmed/hct061. Epub 2013 Mar 28. Erratum in: QJM. 2013 Jun;106(6):567.

38.

Connecticut moves ahead. 1963.

Barger AC, White PD.

Conn Med. 2013 Jan;77(1):55-6. No abstract available.

PMID:
23427375
39.

Views on the nature of chronic fatigue syndrome: content analysis.

Hossenbaccus Z, White PD.

JRSM Short Rep. 2013 Jan;4(1):4. doi: 10.1258/shorts.2012.012051. Epub 2013 Jan 14.

40.

Recovery from chronic fatigue syndrome after treatments given in the PACE trial.

White PD, Goldsmith K, Johnson AL, Chalder T, Sharpe M.

Psychol Med. 2013 Oct;43(10):2227-35. doi: 10.1017/S0033291713000020.

41.

Life course study of the etiology of self-reported irritable bowel syndrome in the 1958 British birth cohort.

Goodwin L, White PD, Hotopf M, Stansfeld SA, Clark C.

Psychosom Med. 2013 Feb;75(2):202-10. doi: 10.1097/PSY.0b013e31827c351b. Epub 2013 Jan 16.

PMID:
23324872
42.

Functional somatic syndromes may be either "polysyndromic" or "monosyndromic".

White PD.

J Psychosom Res. 2013 Jan;74(1):2-3. doi: 10.1016/j.jpsychores.2012.10.005. Epub 2012 Nov 10. No abstract available.

PMID:
23272980
43.

Dose-response analysis of bromate-induced DNA damage and mutagenicity is consistent with low-dose linear, nonthreshold processes.

Spassova MA, Miller DJ, Eastmond DA, Nikolova NS, Vulimiri SV, Caldwell J, Chen C, White PD.

Environ Mol Mutagen. 2013 Jan;54(1):19-35. doi: 10.1002/em.21737. Epub 2012 Sep 26.

PMID:
23015362
44.

Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis.

McCrone P, Sharpe M, Chalder T, Knapp M, Johnson AL, Goldsmith KA, White PD.

PLoS One. 2012;7(8):e40808. doi: 10.1371/journal.pone.0040808. Epub 2012 Aug 1.

45.

Classifying mental and neurological conditions together: authors' reply to letters.

White PD, Rickards H, Zeman AZ.

BMJ. 2012 Jul 23;345:e4906. doi: 10.1136/bmj.e4906. No abstract available.

PMID:
22826589
46.

Time to end the distinction between mental and neurological illnesses.

White PD, Rickards H, Zeman AZ.

BMJ. 2012 May 24;344:e3454. doi: 10.1136/bmj.e3454. No abstract available.

PMID:
22628005
47.

Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome.

Cella M, White PD, Sharpe M, Chalder T.

Psychol Med. 2013 Feb;43(2):375-80. doi: 10.1017/S0033291712000979. Epub 2012 May 9.

PMID:
22571806
48.

A synthesis of the evidence for managing stress at work: a review of the reviews reporting on anxiety, depression, and absenteeism.

Bhui KS, Dinos S, Stansfeld SA, White PD.

J Environ Public Health. 2012;2012:515874. doi: 10.1155/2012/515874. Epub 2012 Feb 14. Review.

49.

Chronic fatigue syndrome: treatment without a cause.

White PD, Chalder T.

Lancet. 2012 Apr 14;379(9824):1372-3. doi: 10.1016/S0140-6736(12)60197-4. Epub 2012 Mar 3. No abstract available.

PMID:
22385681
50.

PACE trial clarification.

Chalder T, Sharpe M, White PD.

Lancet. 2012 Feb 18;379(9816):616. doi: 10.1016/S0140-6736(12)60267-0. No abstract available.

PMID:
22340300

Supplemental Content

Loading ...
Support Center